Idiopathic thrombocytopenic purpura radiation

Idiopathic thrombocytopenic purpura Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Idiopathic thrombocytopenic purpura from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X Ray
CT
MRI
Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Radiation
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Idiopathic thrombocytopenic purpura radiation On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Idiopathic thrombocytopenic purpura radiation All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Idiopathic thrombocytopenic purpura radiation
CDC on Idiopathic thrombocytopenic purpura radiation
Idiopathic thrombocytopenic purpura radiation in the news
Blogs on Idiopathic thrombocytopenic purpura radiation
Directions to Hospitals Treating Idiopathic thrombocytopenic purpura
Risk calculators and risk factors for Idiopathic thrombocytopenic purpura radiation

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Radiation

Splenic radiation (RT) is usually given for steroid-resistant ITP. One to six weeks of 75-1370 cGy with or without concomittant post-RT steroids. Patients can respond for >1 year. It is a safe alternative for patients too old for splenectomy.